Work

Co-Treatment with JAK2 Inhibitor TG101209 and Panobinostat or hsp90 Inhibitor AUY922 Attenuates Mutant JAK2-V617F Levels and Activity in Human Myeloproliferative Disorder Cells

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3739.3739

Authors: Yongchao Wang, Warren Fiskus, Kavita Natarajan, Anand Jillella, Cornelia Quadt, Peter Ataja, Ross Levine, Kapil N. Bhalla

Institutions: Augusta University, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590884920

FWCI: 0.138

Cites:

Cited by: 1

Related to: 10